Hainan Shuangcheng Pharmaceuticals Co., Ltd. (SHE:002693)

Revenue by Segment

Financials in millions CNY. Fiscal year is January - December.

Fiscal Year	FY 2024	FY 2023	FY 2023	FY 2022	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016	FY 2015
Period Ending	Dec 31, 2024	Dec 31, 2023	Jan 1, 2023	Jan 1, 2022	Dec 31, 2020	Dec 31, 2019	Dec 31, 2018	Dec 31, 2017	Dec 31, 2016	Dec 31, 2015
Entrusted R&D Business	43.15M	-	-	-	-
Offset of Business Segment	-390.52K	-	-	-	-
Self-Produced Medicine Sales Business	126.38M	-	-	303.56M	251.48M
Self-Produced Medicine Sales Business Growth	-	-	-	20.71%	0.52%
Other Business	5.07M	-	-	16.74M	17.96M
Other Business Growth	-	-	-	-6.83%	228.65%
Total	174.21M	-	-	320.29M	269.44M
Total Growth	-	-	-	18.87%	-22.27%

Revenue by Geography

Financials in millions CNY. Fiscal year is January - December.

Fiscal Year	FY 2024	FY 2023	FY 2023	FY 2022	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016	FY 2015
Period Ending	Dec 31, 2024	Dec 31, 2023	Jan 1, 2023	Jan 1, 2022	Dec 31, 2020	Dec 31, 2019	Dec 31, 2018	Dec 31, 2017	Dec 31, 2016	Dec 31, 2015
Northeast China Region	3.60M	6.16M	4.06M	3.19M	2.27M
Northeast China Region Growth	-41.62%	51.81%	27.26%	40.46%	-54.75%
North China	9.01M	15.06M	13.02M	28.95M	47.17M
North China Growth	-40.16%	15.70%	-55.05%	-38.62%	10.68%
East China	53.94M	83.70M	87.64M	112.10M	83.83M
East China Growth	-35.56%	-4.50%	-21.81%	33.71%	-32.49%
Southern China	15.07M	60.35M	63.84M	74.02M	57.45M
Southern China Growth	-75.02%	-5.47%	-13.76%	28.84%	-24.32%
Central	15.48M	14.92M	34.25M	36.06M	32.38M
Central Growth	3.70%	-56.43%	-5.01%	11.37%	-48.01%
Northwest China	2.55M	6.33M	8.72M	15.38M	12.33M
Northwest China Growth	-59.78%	-27.40%	-43.33%	24.79%	1.00%
Southwest China	40.34M	46.32M	39.58M	22.67M	18.59M
Southwest China Growth	-12.92%	17.03%	74.57%	21.97%	-23.90%
Foreign	34.23M	3.08M	23.64M	27.91M	15.42M
Foreign Growth	1010.41%	-86.96%	-15.30%	81.02%	-
Total	174.21M	235.93M	274.75M	320.29M	269.44M
Total Growth	-26.16%	-14.13%	-14.22%	18.87%	-22.27%

Source: S&P Global Market Intelligence.